“Non-Invasive Serum and Elastography-Based Markers of Fibrosis Staging in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review”, AGDD, vol. 7, no. 1, pp. 32–6, Jul. 2024, doi: 10.5281/zenodo.22179529.